IDORSIA
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.
IDORSIA
Industry:
Biotechnology Health Care
Founded:
2017-06-01
Status:
Active
Contact:
41 58 844 00 00
Email Addresses:
[email protected]
Total Funding:
1.44 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Apache
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Swords Labs
Bristol-Myers Squibb is a biopharma company that works to discover, and deliver innovative medicines that help patients fight disease.
TransGenex Nanobiotech
TransGenex Nanobiotech is to discover, develop and commercialize nano-scale technologies for novel, cost-effective diagnostic.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-07-23 | Vaxxilon | Vaxxilon acquired by Idorsia | N/A |
Investors List
CARB-X
CARB-X investment in Grant - Idorsia
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-09-20 | Santhera Pharmaceuticals | Idorsia investment in Post-IPO Equity - Santhera Pharmaceuticals | 20 M CHF |
More informations about "Idorsia"
Idorsia | Welcome to Idorsia
To best serve your interest, Idorsia offers an electronic ‘Stay Informed’ service. With this service you have the possibility to automatically receive Idorsia's Media Releases directly to your inbox. In addition, if you provide your mobile phone …See details»
Our People - Idorsia
To reach these high ambitions, we foster a culture of transparency, based on open exchange across the entire organization. We are solution-oriented in our thinking, and we do more with …See details»
Idorsia - Wikipedia
After Actelion was bought by Johnson & Johnson in 2017, [1] Idorsia was spun out into a new company and started operating on the same campus where Actelion was founded under the …See details»
About us - Idorsia
A 100% subsidiary of Idorsia Ltd, based in Lörrach, Germany – performs clinical development on behalf of the Group and acts as the Idorsia’s representative for obtaining regulatory approvals …See details»
Idorsia | Responsibilities
Idorsia's corporate responsibility covers efforts from employee development and diversity, to governance and ethics, as well as the organization’s economic, environmental, and social …See details»
Idorsia - Crunchbase Investor Profile & Investments
In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, …See details»
Our Approach - Idorsia
Idorsia is expanding its global footprint to reach more patients with our transformative treatments. ... The Board of Directors is responsible for providing direction and approval of the organization’s purpose, values, and strategic …See details»
Idorsia | About us
Idorsia is expanding its global footprint to reach more patients with our transformative treatments. We conduct research, clinical development and commercial operations out of the following …See details»
Grants & Sponsorships Global - Powered By Science | Idorsia …
An arrangement where Idorsia provides funds to an organization in return for enabling Idorsia to promote its company name to an audience or to maintain a booth, in accordance with local …See details»
Idorsia | Responsibilities
Idorsia`s corporate responsibility covers efforts from employee development and diversity, to governance and ethics, as well as the organization’s economic, environmental, and social …See details»
Idorsia, a small company with a big portfolio says Martine Clozel
Jan 22, 2019 Idorsia has a portfolio small enough for the management to know all the projects. We can be very efficient in making decisions. Skip to main content. News; Events; ... A small …See details»
Research & Development - Idorsia
Idorsia`s corporate responsibility covers efforts from employee development and diversity, to governance and ethics, as well as the organization’s economic, environmental, and social …See details»
Idorsia | Research & Development
Idorsia’s clinical development comprises a broad spectrum of expertise clustered within multiple units: therapy area units, strategic development, clinical pharmacology, biostatistics and data …See details»
Our strategic priorities - Idorsia
Idorsia engages in strong strategic partnerships, tapping into external resources to realize our objective of changing the treatment paradigm in underserved disorders. Whether such …See details»
About us - Idorsia
Idorsia is expanding its global footprint to reach more patients with our transformative treatments. We conduct research, clinical development and commercial operations out of the following …See details»
Idorsia announces financial results for the first quarter 2025 ...
12 hours ago Lastly, we streamlined the R&D organization to invest in our promising refocused pipeline. All these achievements put us on a solid path to reach our 2025 goals.” ... About …See details»
Grants & Sponsorships US - Powered By Science - Idorsia
An arrangement where Idorsia provides funds to an organization in return for enabling Idorsia to promote its company name to an audience or to maintain a booth, in accordance with local …See details»
Idorsia announces financial results for the first quarter 2025 ...
13 hours ago Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2025. ... Lastly, we streamlined the R&D organization to invest in our promising refocused …See details»
Insomnia - Idorsia
The links provided are for informational purposes only; they do not constitute an endorsement or an approval from Idorsia Pharmaceuticals Ltd of the services or opinions of the corporation, …See details»
Serving patients - Idorsia
Idorsia is expanding its global footprint to reach more patients with our transformative treatments. ... The request must be made by the patient’s treating physician, unsolicited by Idorsia or any …See details»